Predicting Early Disease Recurrence of Pancreatic Cancer following Surgery: Determining the Role of NUDT15 as a Prognostic Biomarker

Predicting Early Disease Recurrence of Pancreatic Cancer following Surgery: Determining the Role of NUDT15 as a Prognostic Biomarker

Surgical resection remains the only curative treatment strategy for Pancreatic Ductal Adenocarcinoma (PDAC). A proportion of patients succumb to early disease recurrence post-operatively despite receiving adjuvant chemotherapy. The ability to identify these high-risk individuals at their initial dia...

Full description

Bibliographic Details
Main Authors: Daniel Llwyd Hughes, Frances Willenbrock, Zahir Soonawalla, Somnath Mukherjee, Eric O’Neill
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Current Oncology
Subjects:
pancreatic cancer
early recurrence
survival
biomarker
prognosis
NUDT15
Online Access:https://www.mdpi.com/1718-7729/29/4/206

Internet

https://www.mdpi.com/1718-7729/29/4/206

Similar Items